Defiance ETFs

Defiance ETFs is a thematic exchange-traded fund (ETF) issuer and registered investment advisor specializing in disruptive technologies and next-generation investment themes. Founded in 2018 and headquartered in Miami, the firm has established a significant presence in the biotechnology and healthcare sectors through specialized products like the Defiance Nasdaq Junior Biotechnology ETF (IBBJ). The company also offers leveraged single-stock ETFs providing amplified exposure to major healthcare innovators such as Moderna, Eli Lilly, and Novo Nordisk. Defiance is recognized for its 'first-mover' strategy, targeting high-growth areas including quantum computing, 5G, and medical innovation. Recently, the firm expanded its healthcare focus by filing for a biopharma-focused ETF that incorporates a philanthropic model to support autism research and services. As an asset manager, Defiance provides retail and institutional investors with liquid and transparent access to transformative global trends.